hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 15:20:49 - browse：74

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： 30 years of 'Listening to Prozac'

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

What don’t we know about an Alzheimer’s drug side effect?

How to pay for weight loss drugs and save Medicare

Fetal surgery at risk from Dobbs and new abortion restrictions

NIH chief: government has fallen behind pharma on clinical trials

explore

hotspot

focus

Hepatitis C has a cure — but many Americans still lack access to it

Ventyx halts psoriasis drug development after lackluster trial results

Hepatitis C has a cure — but many Americans still lack access to it

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Medicare proposal to cover medical devices draws a mixed reaction

As biotech industry slumps, bioscience job market is upside down

Hollywood unions extend contract negotiations for actors

Cigna, Humana reportedly in talks to merge

Hollywood unions extend contract negotiations for actors

A letter from the executive editor: STAT UnitedHealth investigation

hotspot

After decades in use, heart stents finally beat placebo

Fetal surgery at risk from Dobbs and new abortion restrictions

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Fetal surgery at risk from Dobbs and new abortion restrictions

Mayo Clinic plans $5B tech

Publishing genetic code of viruses could cause disaster

knowledge

hotspot

entertainment

hotspot